FindTrial
Sign In

placebo eye drops

DRUG14 trials

Sponsors

Allergan, Alcon Research, Kubota Vision Inc., Fovea Pharmaceuticals SA, ForSight Vision5, Inc.

Conditions

Bacterial ConjunctivitisDiabetic Macular EdemaDry EyeDry Eye Disease (DED)Dry Eye SyndromesGlaucomaKeratoconjunctivitis SiccaMyopia

Phase 1

A Study of TRS01 in Participants With Post-surgical Ocular Inflammation
CompletedNCT04222725
Tarsier PharmaPost Surgical Ocular Inflammation
Start: 2020-02-01End: 2020-07-17Updated: 2021-10-14

Phase 2

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
CompletedNCT01027013
Kubota Vision Inc.Dry Eye Syndromes, Keratoconjunctivitis Sicca
Start: 2009-12-31End: 2010-11-30Updated: 2012-01-11
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
CompletedNCT01057147
Kubota Vision Inc.Dry Eye, Keratoconjunctivitis Sicca
Start: 2010-02-28End: 2011-02-28Updated: 2012-01-11
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
CompletedNCT01319487
Fovea Pharmaceuticals SADiabetic Macular Edema
Start: 2011-05-31End: 2012-06-30Updated: 2012-08-23
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
CompletedNCT01915940
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2013-10-23End: 2014-11-14Updated: 2018-04-20
Dose-Ranging Study of the Bimatoprost Ocular Insert
CompletedNCT02358369
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2015-01-19End: 2015-10-07Updated: 2020-06-04
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
RecruitingNCT07075718
Glaukos CorporationGlaucoma
Start: 2025-06-12End: 2032-03-01Target: 610Updated: 2026-03-02

Phase 3

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
CompletedNCT00509873
AllerganBacterial Conjunctivitis
Start: 2007-08-31End: 2008-06-30Updated: 2011-11-30
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
CompletedNCT00518089
AllerganBacterial Conjunctivitis
Start: 2008-02-29End: 2009-01-31Updated: 2019-04-23
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
RecruitingNCT06708156
Oupushifang Pharmaceutical Technology Co., Ltd.Myopia, Myopia Progression
Start: 2024-06-15End: 2027-12-31Target: 606Updated: 2024-12-24
Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)
RecruitingNCT07028827
Ocus Innovation Ireland LimitedMyopia
Start: 2025-09-01End: 2027-12-31Target: 234Updated: 2026-02-11
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
RecruitingNCT07495852
Glaukos CorporationGlaucoma
Start: 2026-02-17End: 2032-03-01Target: 510Updated: 2026-03-30

Phase 4

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
CompletedNCT00759941
Alcon ResearchGlaucoma
Start: 2007-10-31End: 2009-07-31Updated: 2014-01-13

Unknown Phase

Efficacy and Safety of VMX Eye Drops for Dry Eye Disease
Not yet recruitingNCT07369375
VISUfarma SpADry Eye Disease (DED)
Start: 2026-02-02End: 2026-06-01Target: 76Updated: 2026-01-29

Related Papers

Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.
2022-12-0130 citations